Impact of endpoint selection on sample size calculations for disease-modifying clinical trials in Parkinson's disease patients with GBA1 mutations

被引：0
|
作者：
Simon, David K. [1 ]
Mendonca, Nuno [2 ]
Holenz, Joerg [3 ]
Liu, Jennifer [1 ]
Castilla-Fernandez, Guillermo [2 ]
Fonseca, Miguel M. [3 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA USA
[2] Bial R&D Investments SA, Coronado, Portugal
[3] Bial Portela & Ca SA, Coronado, Portugal
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
POSTER 28
引用
收藏
页码：S10 / S11
页数：2
相关论文
共 50 条
  • [1] Impact of Endpoint Selection on Sample Size Calculations for Disease-modifying Clinical Trials in Parkinson's Disease Patients with GBA1 Mutations
    Fonseca, M.
    Castilla-Fernandez, G.
    Liu, J.
    Holenz, J.
    Mendonca, N.
    Simon, D.
    MOVEMENT DISORDERS, 2023, 38 : S23 - S23
  • [2] Gene Therapy for Parkinson's Disease Associated with GBA1 Mutations
    Abeliovich, Asa
    Hefti, Franz
    Sevigny, Jeffrey
    JOURNAL OF PARKINSONS DISEASE, 2021, 11 : S183 - S188
  • [3] Understanding Susceptibility of Parkinson's Disease Due to GBA1 Mutations
    Davis, Marie Y.
    Germanos, Alexandre A.
    Yu, Selina
    Thomas, Ruth E.
    Pallanck, Leo J.
    ANNALS OF NEUROLOGY, 2017, 82 : S213 - S214
  • [4] Contrasting Olfactory Perception in Parkinson's disease (PD): Impact of GBA1 Gene Mutations
    Schechter, Y.
    Dominko, M.
    Cohen, M.
    Yahalom, G.
    Zimran, A.
    Revel-Vilk, S.
    Shulman, E.
    Dinur, T.
    Cohen, M. Becker
    MOVEMENT DISORDERS, 2024, 39 : S140 - S140
  • [5] The role of GBA1 mutations in the relationship between GBA1 and alpha-synuclein in Parkinson disease
    Smith, L.
    Gegg, M.
    Chau, D.
    Schapira, A. H. V.
    MOVEMENT DISORDERS, 2022, 37 : S595 - S595
  • [6] Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations?
    Kopytova, Alena E.
    Usenko, Tatiana S.
    Baydakova, Galina V.
    Nikolaev, Mikhail A.
    Senkevich, Konstantin A.
    Izyumchenko, Artem D.
    Tyurin, Alexandr A.
    Miliukhina, Irina V.
    Emelyanov, Anton K.
    Zakharova, Ekaterina Y.
    Pchelina, Sofya N.
    MOVEMENT DISORDERS, 2022, 37 (08) : 1779 - 1781
  • [7] Molecular mechanisms of α-synuclein and GBA1 in Parkinson's disease
    Stojkovska, Iva
    Krainc, Dimitri
    Mazzulli, Joseph R.
    CELL AND TISSUE RESEARCH, 2018, 373 (01) : 51 - 60
  • [8] Molecular mechanisms of α-synuclein and GBA1 in Parkinson’s disease
    Iva Stojkovska
    Dimitri Krainc
    Joseph R. Mazzulli
    Cell and Tissue Research, 2018, 373 : 51 - 60
  • [9] Sample Size Calculations for Detecting Disease-Modifying Osteoarthritis Drug Effects on Knee Replacement Incidence in Clinical Trials
    Ried, Janina S.
    Flechsenhar, Klaus
    Bartnik, Eckart
    Crowther, Daniel
    Dietrich, Axel
    Eckstein, Felix
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (12) : 3174 - 3183
  • [10] A Novel Role for Glucocerebrosidase 1 (GBA1) in Parkinson's Disease
    Jayabalan, Nanthini
    Roper, Katherine
    Woodhouse, Helen M.
    Adam, Robert J.
    O'Sullivan, John D.
    Gordon, Richard
    FASEB JOURNAL, 2022, 36
12345